Literature DB >> 7375231

Rubella susceptibility in sixth graders: effectiveness of current immunization practice.

M R Lawless, J S Abramson, J E Harlan, D S Kelsey.   

Abstract

Rubella hemagglutination inhibition antibody titer was determined for 702 sixth grade students from nine randomly chosen schools in a community served well medically. Rubella immunization had been given by private physicians, the health department, hospital clinics, and through a mass immunization effort in 1970. The overall susceptibility rate, as defined by a rubella hemagglutination inhibition titer of less than 1:8, was 15%. Susceptibility did not differ significantly in regard to sex, race, or source of vaccine. Of 469 children with a documented rubella immunization, 13.2% were susceptible or vaccine failures. Menarche was reported by 30% of the girls. To increase the level of protection against rubella during the childbearing years, continued emphasis on early childhood immunization combined with consideration of a booster rubella immunization for preadolescents is recommended.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7375231

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  4 in total

1.  Increasing rubella seronegativity despite a compulsory school law.

Authors:  T R Schum; D B Nelson; M A Duma; G V Sedmak
Journal:  Am J Public Health       Date:  1990-01       Impact factor: 9.308

2.  Rubella susceptibility in inner-city adolescents: the effect of a school immunization law.

Authors:  D B Nelson; M M Layde; T B Chatton
Journal:  Am J Public Health       Date:  1982-07       Impact factor: 9.308

3.  Public health implications of rubella antibody levels in California.

Authors:  L G Dales; J Chin
Journal:  Am J Public Health       Date:  1982-02       Impact factor: 9.308

4.  Seroepidemiology of rubella in Saudi Arabia: an adapted vaccination policy.

Authors:  M A Abdullah; G Jamjoom; Z A Karrar; A Badreldine; N Al Jishi; S A Taha
Journal:  J Epidemiol Community Health       Date:  1984-09       Impact factor: 3.710

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.